In the past four decades, skull base surgery has undergone dramatic paradigm shifts. Evolution in understanding of physiology and anatomy coupled with advances in technology and training have completely revolutionized management of patients with benign and malignant conditions of the anterior skull base. The "Skull Base Surgeon" requires broad and deep knowledge related to pathology, surgical approach and reconstruction with open and endoscopic techniques, perioperative management, and adjuvant and neoadjuvant indications and techniques. The ability of skull base surgeons has decreased the morbidity and mortality of these surgeries and has expanded and continued to expand the frontiers of pathology accessible. With the improvements in technology allowing minimally invasive access to the skull base, we have begun to focus on assessment of quality of life and patient reported outcomes. With these assessments we can truly begin to identify what matters most to patients and allow them to be true partners in care. In addition, we are seeing dramatic changes in understanding of genomics and immunotherapeutics. As is often true in medicine, as we begin to comprehend more of the issues around diagnosis and treatment of skull base tumors, we encounter more questions than we started with. It is apparent that much work remains to be done; however, this issue highlights the recent advances in skull base tumor management.

In this special edition of the World Journal of Otorhinolaryngology Head and Neck Surgery, we cover many of the exciting areas of progress including knowledge of both benign and malignant conditions of the anterior skull base. The international group of experts that contributed to this issue speak on a wide range of topics related to their specific areas of research and clinical care ranging from evidence-based guidelines for perioperative management during pituitary surgery to endoscopic approaches to the petrous apex, infratemporal fossa, orbit, craniovertebral junction as well as review of the cutting edge on treatment clival chordomas and pediatric skull base tumors. We finish the issue reviewing advances in reconstruction after open skull base surgery and then assess what can be gleaned using a large national database to see trends in the rare diagnosis of sinonasal and skull base squamous cell carcinoma.
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